Compile Data Set for Download or QSAR
Report error Found 94 Enz. Inhib. hit(s) with all data for entry = 13352
TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783192(US20250326769, Example 76)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

LigandPNGBDBM783191(US20250326769, Example 66)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Nuvalent

US Patent
LigandPNGBDBM783191(US20250326769, Example 66)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783190(US20250326769, Example 58)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783157(US20250326769, Example 8)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

LigandPNGBDBM783157(US20250326769, Example 8)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Nuvalent

US Patent
LigandPNGBDBM783157(US20250326769, Example 8)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Nuvalent

US Patent
LigandPNGBDBM783156((Method C) | US20250326769, Example 7)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783156((Method C) | US20250326769, Example 7)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

LigandPNGBDBM783156((Method C) | US20250326769, Example 7)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Nuvalent

US Patent
LigandPNGBDBM783156((Method C) | US20250326769, Example 7)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783160(US20250326769, Example 11)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783159(US20250326769, Example 10)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783158(US20250326769, Example 9)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

LigandPNGBDBM783158(US20250326769, Example 9)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Nuvalent

US Patent
LigandPNGBDBM783158(US20250326769, Example 9)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783155(US20250326769, Example 6)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Nuvalent

US Patent
LigandPNGBDBM783154((Method B) | US20250326769, Example 5)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783154((Method B) | US20250326769, Example 5)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

LigandPNGBDBM783153(US20250326769, Example 4)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Nuvalent

US Patent
LigandPNGBDBM783153(US20250326769, Example 4)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783152(US20250326769, Example 3)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783171(US20250326769, Example 31)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783170(US20250326769, Example 30)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Nuvalent

US Patent
LigandPNGBDBM783169(US20250326769, Example 27)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783169(US20250326769, Example 27)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

LigandPNGBDBM783169(US20250326769, Example 27)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Nuvalent

US Patent
LigandPNGBDBM783169(US20250326769, Example 27)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783175(US20250326769, Example 35)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783174(US20250326769, Example 34)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783173(US20250326769, Example 33)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783172(US20250326769, Example 32)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Nuvalent

US Patent
LigandPNGBDBM783163(US20250326769, Example 14)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783163(US20250326769, Example 14)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783162(US20250326769, Example 13)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783161(US20250326769, Example 12)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783168(US20250326769, Example 20)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Nuvalent

US Patent
LigandPNGBDBM783167(US20250326769, Example 19)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783167(US20250326769, Example 19)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783166(US20250326769, Example 18)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783165(US20250326769, Example 17)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Nuvalent

US Patent
LigandPNGBDBM783187((Method D) | US20250326769, Example 49)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783185(US20250326769, Example 45)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783184(US20250326769, Example 44)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Nuvalent

US Patent
LigandPNGBDBM783183(US20250326769, Example 43)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

LigandPNGBDBM783190(US20250326769, Example 58)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Nuvalent

US Patent
LigandPNGBDBM783190(US20250326769, Example 58)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783188(US20250326769, Example 55)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783187((Method D) | US20250326769, Example 49)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetALK tyrosine kinase receptor [I1171N,D1203N](Homo sapiens (Human))
Nuvalent

US Patent
LigandPNGBDBM783179((Method H) | US20250326769, Example 39)
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

Displayed 1 to 50 (of 94 total ) | Next | Last >>
Jump to: